This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Histone-arginine methyltransferase CARM1.
Throughout myogenic transcriptional activation, acts together with NCOA3/ACTR as a coactivator for MEF2C. Throughout monocyte inflammatory stimulation, acts together with EP300/P300 as a coactivator for NF-kappa-B.
| Human | |
|---|---|
| Gene Name: | CARM1 |
| Uniprot: | Q86X55 |
| Entrez: | 10498 |

| Belongs to: |
|---|
| class I-like SAM-binding methyltransferase superfamily |

Carm1; coactivator-associated arginine methyltransferase 1EC 2.1.1.-; EC 2.1.1; histone-arginine methyltransferase CARM1; PRMT4; PRMT4EC 2.1.1.125; Protein arginine N-methyltransferase 4
Mass (kDA):
65.854 kDA

| Human | |
|---|---|
| Location: | 19p13.2 |
| Sequence: | 19; NC_000019.10 (10871553..10923078) |
Overexpressed in prostate adenocarcinomas and high-grade prostatic intraepithelial neoplasia.
Nucleus. Cytoplasm. Mainly nuclear during the G1, S and G2 phases of the cell cycle. Cytoplasmic during mitosis, after breakup of the nuclear membrane.






PMID: 12237300 by Li H., et al. Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase.
PMID: 15221992 by Hong H., et al. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.